Kristen C. Cooke

Kristen C. Cooke

Auto-generated profile, based on publicly available information

Kristen C. Cooke

School of Life and Environmental Sciences, University of Sydney, Camperdown, New South Wales, Australia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TNTina Nguyen
Tina Nguyen
ALAnthony Lau
Anthony Lau
JBJulia Bier
Julia Bier
KCKristen C. Cooke
Kristen C. Cooke
HLHelen Lenthall
Helen Lenthall
EDElissa K. Deenick
Elissa K. Deenick
Heterozygous loss-of-function (LOF) mutations in PIK3R1 (encoding phosphatidylinositol 3-kinase [PI3K] regulatory subunits) cause activated PI3Kδ syndrome 2 (APDS2), which has a similar clinical profile to APDS1, caused by heterozygous gain-of-function (GOF) mutations in PIK3CD (encoding the PI3K p110δ catalytic subunit). While several studies have established how PIK3CD GOF leads to immune dysregulation, less is known about how PIK3R1 LOF mutations alter cellular function. By studying a novel CRISPR/Cas9 mouse model and patients’ immune cells, we determined how PIK3R1 LOF alters cellular function. We observed some overlap in cellular defects in APDS1 and APDS2, including decreased intrinsic B cell class switching and defective Tfh cell function. However, we also identified unique APDS2 phenotypes including defective expansion and affinity maturation of Pik3r1 LOF B cells following immunization, and decreased survival of Pik3r1 LOF pups. Further, we observed clear differences in the way Pik3r1 LOF and Pik3cd GOF altered signaling. Together these results demonstrate crucial differences between these two genetic etiologies.

25 October 2022 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
ADAlexis Diaz-Vegas
Alexis Diaz-Vegas
DNDougall M Norris
Dougall M Norris
SJSigrid Jall-Rogg
Sigrid Jall-Rogg
KCKristen C Cooke
Kristen C Cooke
OCOlivia J Conway
Olivia J Conway
JBJames G Burchfield
James G Burchfield
Insulin-induced GLUT4 translocation to the plasma membrane in muscle and adipocytes is crucial for whole-body glucose homeostasis. Currently, GLUT4 trafficking assays rely on overexpression of tagged GLUT4. Here we describe a high-content imaging platform for studying endogenous GLUT4 translocation in intact adipocytes. This method enables high fidelity analysis of GLUT4 responses to specific perturbations, multiplexing of other trafficking proteins and other features including lipid droplet morphology. Using this multiplexed approach we showed that Vps45 and Rab14 are selective regulators of GLUT4, butTrarg1,Stx6,Stx16,Tbc1d4andRab10knockdown affected both GLUT4 and TfR translocation. Thus, GLUT4 and TfR translocation machinery likely have some overlap upon insulin-stimulation. In addition, we identified Kif13A, a Rab10 binding molecular motor, as a novel regulator of GLUT4 traffic. Finally, comparison of endogenous to overexpressed GLUT4 highlights that the endogenous GLUT4 methodology has an enhanced sensitivity to genetic perturbations and emphasises the advantage of studying endogenous protein trafficking for drug discovery and genetic analysis of insulin action in relevant cell types.

13 June 2025 in Science Advances
Verified
Journal Article
Open access
HCHarry B. Cutler
Harry B. Cutler
SJSigrid Jall-Rogg
Sigrid Jall-Rogg
STSenthil Thillainadesan
Senthil Thillainadesan
KCKristen C. Cooke
Kristen C. Cooke
SMStewart W. C. Masson
Stewart W. C. Masson
SMSøren Madsen
Søren Madsen
To gain insight into the root causes of metabolic dysfunction, it is essential to understand how tissues communicate and coordinate their metabolic functions. Here, we sought to address this in the context of cold exposure, a well-studied metabolic perturbation. We performed proteomics across six metabolic tissues and plasma, quantifying 11,394 proteins. Beginning our investigation in brown adipose tissue (BAT), we identified a mechanism to explain enhanced glucose utilization in cold-adapted BAT. This was characterized by select remodeling of upper glycolysis and pentose cycling to increase oxygen consumption, likely by increasing uncoupling protein 1 activity through the production of reactive oxygen species. Cold-induced remodeling of the plasma proteome appeared to underpin the ability of BAT to modify its fuel preference, stimulating lipolysis in white adipose tissue and glucose production in the liver. These findings emphasize the importance of considering metabolic adaptations in the context of the whole body and suggest overlap between the mechanisms of cold adaptation and obesity.

12 September 2023 in Diabetes
Verified
Journal Article
Open access
PDF file
HCHarry B. Cutler
Harry B. Cutler
SMSøren Madsen
Søren Madsen
SMStewart W.C. Masson
Stewart W.C. Masson
KCKristen C. Cooke
Kristen C. Cooke
MPMeg Potter
Meg Potter
DJDavid E. James
David E. James
The ability of metabolically active tissues to increase glucose uptake in response to insulin is critical to whole-body glucose homeostasis. This report describes the Dual Tracer Test, a robust method involving sequential retro-orbital injection of [14C]2-deoxyglucose ([14C]2DG) alone, followed 40 min later by injection of [3H]2DG with a maximal dose of insulin to quantify both basal and insulin-stimulated 2DG uptake in the same mouse. The collection of both basal and insulin-stimulated measures from a single animal is imperative for generating high-quality data since differences in insulin action may be misinterpreted mechanistically if basal glucose uptake is not accounted for. The approach was validated in a classic diet-induced model of insulin resistance and a novel transgenic mouse with reduced GLUT4 expression that, despite ubiquitous peripheral insulin resistance, did not exhibit fasting hyperinsulinemia. This suggests that reduced insulin-stimulated glucose disposal is not a primary contributor to chronic hyperinsulinemia. The Dual Tracer Test offers a technically simple assay that enables the study of insulin action in many tissues simultaneously. By administering two tracers and accounting for both basal and insulin-stimulated glucose transport, this assay halves the required sample size for studies in inbred mice and demonstrates increased statistical power to detect insulin resistance, relative to other established approaches, using a single tracer. The Dual Tracer Test is a valuable addition to the metabolic phenotyping toolbox. Article Highlights:

13 March 2024 in medRxiv
Verified
Preprint
Open access
PDF file
ENElise J. Needham
Elise J. Needham
JHJanne R. Hingst
Janne R. Hingst
JOJohan D. Onslev
Johan D. Onslev
ADAlexis Diaz-Vegas
Alexis Diaz-Vegas
MLMagnus R. Leandersson
Magnus R. Leandersson
JWJørgen F. P. Wojtaszewski
Jørgen F. P. Wojtaszewski
Type 2 diabetes is preceded by a defective insulin response, yet our knowledge of the precise mechanisms is incomplete. Here, we investigate how insulin resistance alters signalling responses in skeletal muscle and how this is modified by exercise. We measured parallel phenotypes and phosphoproteomes of insulin resistant and insulin sensitive individuals as they responded to exercise and insulin (n=19, 114 biopsies), quantifying over 12,000 phosphopeptides in each biopsy. Our personalized phosphoproteomics approach revealed that insulin resistant individuals have selective and time-dependent signalling alterations. Insulin resistant subjects have reduced insulin-stimulated mTORC1 responses and alterations to non-canonical rather than canonical insulin signalling. Prior exercise promotes insulin sensitivity even in insulin resistant individuals by ‘priming’ a portion of insulin signalling prior to insulin infusion. This includes MINDY1 S441, which is elevated in insulin-sensitive subjects and primed by prior exercise. MINDY1 contains a missense variant that is protective for type 2 diabetes but its role in disease risk is unknown. We show that MINDY1 S441 phosphorylation is downstream of AKT, and MINDY1 knockdown enhances insulin-stimulated glucose uptake in rat myotubes. This work delineates the signalling alterations in insulin resistant skeletal muscle and how exercise partially counteracts these and identifies MINDY1 as a regulator of insulin action. Highlights Insulin resistance primarily alters non-canonical insulin signalling. mTORC1 substrates were most defective in insulin resistance. Exercise counteracts insulin signalling defects including MINDY1 S441. MINDY1 is a negative regulator of insulin sensitivity in rat myotubes and S441 is downstream of AKT.